SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001047469-18-004849
Filing Date
2018-07-02
Accepted
2018-07-02 16:52:35
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-1/A a2236154zs-1a.htm S-1/A 92465
2 EX-4.1 a2236154zex-4_1.htm EX-4.1 5320
3 EX-10.5 a2236154zex-10_5.htm EX-10.5 26753
4 EX-10.6 a2236154zex-10_6.htm EX-10.6 124432
5 EX-10.7 a2236154zex-10_7.htm EX-10.7 130962
6 EX-10.8 a2236154zex-10_8.htm EX-10.8 114831
7 EX-10.9 a2236154zex-10_9.htm EX-10.9 116660
8 G94142KU01I001.GIF g94142ku01i001.gif GRAPHIC 208116
9 G94142KU01I002.GIF g94142ku01i002.gif GRAPHIC 115086
  Complete submission text file 0001047469-18-004849.txt   1057634
Mailing Address 325 VASSAR STREET, SUITE 1A CAMBRIDGE MA 02139
Business Address 325 VASSAR STREET, SUITE 1A CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-225840 | Film No.: 18933418
SIC: 2836 Biological Products, (No Diagnostic Substances)